PUBLISHER: KBV Research | PRODUCT CODE: 1431156
PUBLISHER: KBV Research | PRODUCT CODE: 1431156
Asia Pacific Pancrelipase Market Size, Share & Trends Analysis Report By Age (Adults & Geriatrics, and Children), By Distribution Channel, By Application (Chronic Pancreatitis, Cystic Fibrosis, and Others), By Country and Growth Forecast, 2023 - 2030
The Asia Pacific Pancrelipase Market would witness market growth of 6.1% CAGR during the forecast period (2023-2030).
Cystic fibrosis, a genetic disease affecting the respiratory, digestive, and reproductive systems, leads to pancreatic insufficiency. This drug is a cornerstone in CF management, mitigating malabsorption issues and ensuring proper nutrition. Individuals with chronic pancreatitis often experience a decline in pancreatic function. This drug becomes instrumental in managing symptoms, preventing malnutrition, and improving the quality of life for patients grappling with this debilitating condition.
Real-world evidence obtained through health economics and outcome research (HEOR) studies provides insights into the drug's long-term effectiveness and safety in diverse patient populations. This evidence is crucial for translating clinical trial outcomes into real-world clinical practice. Health economic modeling helps predict the long-term implications of using this drug to manage pancreatic disorders. These models provide decision-makers with insights into the economic sustainability of therapy. HEOR studies conduct budget impact analyses to estimate the financial consequences of incorporating this medicine into healthcare budgets.
According to Invest India, the telemedicine industry is India's maximum potential eHealth segment, which is expected to reach $5.4 Bn by 2025. Telemedicine platforms can provide prescription services for this medicine and allow for easy refills. Patients with chronic pancreatic conditions can receive ongoing care and prescription renewals through virtual consultations, promoting treatment continuity. Telemedicine facilitates access to specialized healthcare professionals, including gastroenterologists who specialize in diagnosing and treating pancreatic disorders. Patients in remote or underserved areas can consult with experts without extensive travel. Therefore, the factors mentioned above will propel the market growth in this region.
The China market dominated the Asia Pacific Pancrelipase Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $143.5 Million by 2030. The Japan market is registering a CAGR of 5.4% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 6.8% during (2023 - 2030).
Based on Age, the market is segmented into Adults & Geriatrics, and Children. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on Application, the market is segmented into Chronic Pancreatitis, Cystic Fibrosis, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
List of Key Companies Profiled
- Organon & Co.
- Digestive Care, Inc.
- AbbVie, Inc.
- Vivus LLC
- Laboratorio Opoterapico Argentino S.A.
- Nestle S.A
- Scientific Protein Laboratories, LLC (Hepalink)
Asia Pacific Pancrelipase Market Report Segmentation
By Age
- Adults & Geriatrics
- Children
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Application
- Chronic Pancreatitis
- Cystic Fibrosis
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Asia Pacific Pancrelipase Market, by Age
- 1.4.2 Asia Pacific Pancrelipase Market, by Distribution Channel
- 1.4.3 Asia Pacific Pancrelipase Market, by Application
- 1.4.4 Asia Pacific Pancrelipase Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market at a Glance
- 2.1 Key Highlights
Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.1.1 Overview
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- 3.3 Porter Five Forces Analysis
Chapter 4. Asia Pacific Pancrelipase Market by Age
- 4.1 Asia Pacific Adults & Geriatrics Market by Country
- 4.2 Asia Pacific Children Market by Country
Chapter 5. Asia Pacific Pancrelipase Market by Distribution Channel
- 5.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
- 5.2 Asia Pacific Hospital Pharmacies Market by Country
- 5.3 Asia Pacific Online Pharmacies Market by Country
Chapter 6. Asia Pacific Pancrelipase Market by Application
- 6.1 Asia Pacific Chronic Pancreatitis Market by Country
- 6.2 Asia Pacific Cystic Fibrosis Market by Country
- 6.3 Asia Pacific Others Market by Country
Chapter 7. Asia Pacific Pancrelipase Market by Country
- 7.1 China Pancrelipase Market
- 7.1.1 China Pancrelipase Market by Age
- 7.1.2 China Pancrelipase Market by Distribution Channel
- 7.1.3 China Pancrelipase Market by Application
- 7.2 Japan Pancrelipase Market
- 7.2.1 Japan Pancrelipase Market by Age
- 7.2.2 Japan Pancrelipase Market by Distribution Channel
- 7.2.3 Japan Pancrelipase Market by Application
- 7.3 India Pancrelipase Market
- 7.3.1 India Pancrelipase Market by Age
- 7.3.2 India Pancrelipase Market by Distribution Channel
- 7.3.3 India Pancrelipase Market by Application
- 7.4 South Korea Pancrelipase Market
- 7.4.1 South Korea Pancrelipase Market by Age
- 7.4.2 South Korea Pancrelipase Market by Distribution Channel
- 7.4.3 South Korea Pancrelipase Market by Application
- 7.5 Singapore Pancrelipase Market
- 7.5.1 Singapore Pancrelipase Market by Age
- 7.5.2 Singapore Pancrelipase Market by Distribution Channel
- 7.5.3 Singapore Pancrelipase Market by Application
- 7.6 Malaysia Pancrelipase Market
- 7.6.1 Malaysia Pancrelipase Market by Age
- 7.6.2 Malaysia Pancrelipase Market by Distribution Channel
- 7.6.3 Malaysia Pancrelipase Market by Application
- 7.7 Rest of Asia Pacific Pancrelipase Market
- 7.7.1 Rest of Asia Pacific Pancrelipase Market by Age
- 7.7.2 Rest of Asia Pacific Pancrelipase Market by Distribution Channel
- 7.7.3 Rest of Asia Pacific Pancrelipase Market by Application
Chapter 8. Company Profiles
- 8.1 Organon & Co.
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.2 Digestive Care, Inc.
- 8.2.1 Company Overview
- 8.3 Laboratorio Opoterapico Argentino S.A.
- 8.3.1 Company Overview
- 8.4 Scientific Protein Laboratories, LLC (Hepalink)
- 8.4.1 Company Overview
- 8.5 AbbVie, Inc.
- 8.5.1 Company Overview
- 8.5.2 Financial Analysis
- 8.5.3 Regional Analysis
- 8.5.4 Research & Development Expense
- 8.5.5 SWOT Analysis
- 8.6 Vivus LLC
- 8.6.1 Company Overview
- 8.7 Nestle S.A
- 8.7.1 Company Overview
- 8.7.2 Financial Analysis
- 8.7.3 Segmental and Regional Analysis
- 8.7.4 Research & Development Expenses
- 8.7.5 SWOT Analysis
LIST OF TABLES
- TABLE 1 Asia Pacific Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 2 Asia Pacific Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 3 Asia Pacific Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 4 Asia Pacific Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 5 Asia Pacific Adults & Geriatrics Market by Country, 2019 - 2022, USD Million
- TABLE 6 Asia Pacific Adults & Geriatrics Market by Country, 2023 - 2030, USD Million
- TABLE 7 Asia Pacific Children Market by Country, 2019 - 2022, USD Million
- TABLE 8 Asia Pacific Children Market by Country, 2023 - 2030, USD Million
- TABLE 9 Asia Pacific Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 10 Asia Pacific Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 11 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 12 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 13 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 14 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 15 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 16 Asia Pacific Online Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 17 Asia Pacific Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 18 Asia Pacific Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 19 Asia Pacific Chronic Pancreatitis Market by Country, 2019 - 2022, USD Million
- TABLE 20 Asia Pacific Chronic Pancreatitis Market by Country, 2023 - 2030, USD Million
- TABLE 21 Asia Pacific Cystic Fibrosis Market by Country, 2019 - 2022, USD Million
- TABLE 22 Asia Pacific Cystic Fibrosis Market by Country, 2023 - 2030, USD Million
- TABLE 23 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
- TABLE 24 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
- TABLE 25 Asia Pacific Pancrelipase Market by Country, 2019 - 2022, USD Million
- TABLE 26 Asia Pacific Pancrelipase Market by Country, 2023 - 2030, USD Million
- TABLE 27 China Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 28 China Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 29 China Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 30 China Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 31 China Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 32 China Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 33 China Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 34 China Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 35 Japan Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 36 Japan Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 37 Japan Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 38 Japan Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 39 Japan Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 40 Japan Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 41 Japan Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 42 Japan Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 43 India Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 44 India Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 45 India Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 46 India Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 47 India Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 48 India Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 49 India Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 50 India Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 51 South Korea Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 52 South Korea Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 53 South Korea Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 54 South Korea Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 55 South Korea Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 56 South Korea Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 57 South Korea Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 58 South Korea Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 59 Singapore Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 60 Singapore Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 61 Singapore Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 62 Singapore Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 63 Singapore Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 64 Singapore Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 65 Singapore Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 66 Singapore Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 67 Malaysia Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 68 Malaysia Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 69 Malaysia Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 70 Malaysia Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 71 Malaysia Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 72 Malaysia Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 73 Malaysia Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 74 Malaysia Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 75 Rest of Asia Pacific Pancrelipase Market, 2019 - 2022, USD Million
- TABLE 76 Rest of Asia Pacific Pancrelipase Market, 2023 - 2030, USD Million
- TABLE 77 Rest of Asia Pacific Pancrelipase Market by Age, 2019 - 2022, USD Million
- TABLE 78 Rest of Asia Pacific Pancrelipase Market by Age, 2023 - 2030, USD Million
- TABLE 79 Rest of Asia Pacific Pancrelipase Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 80 Rest of Asia Pacific Pancrelipase Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 81 Rest of Asia Pacific Pancrelipase Market by Application, 2019 - 2022, USD Million
- TABLE 82 Rest of Asia Pacific Pancrelipase Market by Application, 2023 - 2030, USD Million
- TABLE 83 Key Information - Organon & co.
- TABLE 84 Key Information - Digestive Care, Inc.
- TABLE 85 Key Information - Laboratorio Opoterapico Argentino S.A.
- TABLE 86 Key Information - Scientific Protein Laboratories, LLC
- TABLE 87 Key information - AbbVie, Inc.
- TABLE 88 Key Information - Vivus LLC
- TABLE 89 Key Information - Nestle S.A
